Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome
Aram Kim, Bumjin Lim, Miho Song, Myung-Soo Choo
Int Neurourol J. 2014;18(3):163-167. Published online 2014 Sep 24 DOI: https://doi.org/10.5213/inj.2014.18.3.163
Citations to this article as recorded by 
Efficacy and predictive factors of clinical response to hyaluronic acid ＋ chondroitin sulfate bladder instillations for the treatment of BPS/IC
G. Polisini, E. Ammirati, P. Geretto, A. Manassero, A. Giammò
Continence.2024; 10: 101224. CrossRef
Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin‐A injections improve sexual function?
Murat Topcuoglu, Murat Can Karaburun, Arif İbiş, Mehmet İlker Gokce, Evren Süer, Omer Gülpinar
Neurourology and Urodynamics.2023; 42(3): 607. CrossRef
Bladder pain syndrome and sexual function: a systematic review and meta-analysis
A. Sobti, S. Shawer, P. Ballard, A. Khunda
International Urogynecology Journal.2023; 34(10): 2359. CrossRef
Interstitial Cystitis/Bladder Pain Syndrome Treatment: A Systematic Review of Sexual Health Outcomes
Andrew Chen, Robert H. Shahiyan, Jennifer T. Anger
Sexual Medicine Reviews.2022; 10(1): 71. CrossRef
Modulation of hyaluronan signaling as a therapeutic target in human disease
Stavros Garantziotis
Pharmacology & Therapeutics.2022; 232: 107993. CrossRef
Intravesical Therapy for BPS/IC
Wyndaele Jean-Jacques
Current Bladder Dysfunction Reports.2021; 16(1): 6. CrossRef
Factors associated with treatment outcomes after intravesical hyaluronic acid therapy in women with refractory interstitial cystitis: A prospective, multicenter study
Ching-Pei Tsai, Jenn-Ming Yang, So-Jung Liang, Yi-Hao Lin, Wen-Chu Huang, Tzu-Yin Lin, Chun-Shuo Hsu, Fei-Chi Chuang, Man-Jung Hung
Journal of the Chinese Medical Association.2021; 84(4): 418. CrossRef
Phenotypes of BPS/IC
Sachin Malde, Arun Sahai
Current Bladder Dysfunction Reports.2020; 15(3): 203. CrossRef
GAG replenishment therapy for bladder pain syndrome/interstitial cystitis
Jean Jacques J Wyndaele, Claus Riedl, Rajesh Taneja, Sándor Lovász, Tomohiro Ueda, Mauro Cervigni
Neurourology and Urodynamics.2019; 38(2): 535. CrossRef
Uropathogenic Escherichia coli and the related virulence factors
Benyamin Salmani Pour Noghlbari, Mahsa Mozaffari
Ginecologia.ro.2019; 4(26): 44. CrossRef
Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion
Aram Kim, Ju‐Young Han, Chae‐Min Ryu, Hwan Yeul Yu, Seungun Lee, YongHwan Kim, Se Un Jeong, Yong Mee Cho, Dong‐Myung Shin, Myung‐Soo Choo
Histopathology.2017; 71(3): 415. CrossRef
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment
Aram Kim, Kyeong-Ok Hoe, Jung Hyun Shin, Myung-Soo Choo
Investigative and Clinical Urology.2017; 58(5): 353. CrossRef
Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome
Aram Kim, Dong-Myung Shin, Myung-Soo Choo
Current Urology Reports.2016;[Epub] CrossRef
The use of intravesical hyaluronic acid for recurrent urinary tract infections in children: a case-series study
Kibriya Fidan, Bahar Büyükkaragöz, Onur Özen, Billur Demirogullari, Oguz Söylemezoglu
Renal Failure.2015; 37(10): 354. CrossRef
Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective
Tae Young Jang, Young Hyo Kim
International Neurourology Journal.2015; 19(3): 142. CrossRef